240 related articles for article (PubMed ID: 30059634)
1. Modeling the influence of chronopharmacological administration of synthetic glucocorticoids on the hypothalamic-pituitary-adrenal axis.
Rao RT; Scherholz ML; Androulakis IP
Chronobiol Int; 2018 Nov; 35(12):1619-1636. PubMed ID: 30059634
[TBL] [Abstract][Full Text] [Related]
2. Modeling inter-sex and inter-individual variability in response to chronopharmacological administration of synthetic glucocorticoids.
Scherholz ML; Rao RT; Androulakis IP
Chronobiol Int; 2020 Feb; 37(2):281-296. PubMed ID: 31797700
[TBL] [Abstract][Full Text] [Related]
3. The Physiological and Pharmacological Significance of the Circadian Timing of the HPA Axis: A Mathematical Modeling Approach.
Li Y; Lu L; Androulakis IP
J Pharm Sci; 2024 Jan; 113(1):33-46. PubMed ID: 37597751
[TBL] [Abstract][Full Text] [Related]
4. Predictive modeling of the hypothalamic-pituitary-adrenal (HPA) axis response to acute and chronic stress.
Marković VM; Čupić Ž; Vukojević V; Kolar-Anić L
Endocr J; 2011; 58(10):889-904. PubMed ID: 21852742
[TBL] [Abstract][Full Text] [Related]
5. Evidence for altered hypothalamus-pituitary-adrenal axis functioning in systemic hypertension: blunted cortisol response to awakening and lower negative feedback sensitivity.
Wirtz PH; von Känel R; Emini L; Ruedisueli K; Groessbauer S; Maercker A; Ehlert U
Psychoneuroendocrinology; 2007 Jun; 32(5):430-6. PubMed ID: 17433557
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional implications of ultradian glucocorticoid secretion in homeostasis and in the acute stress response.
Scheff JD; Calvano SE; Lowry SF; Androulakis IP
Physiol Genomics; 2012 Feb; 44(2):121-9. PubMed ID: 22128089
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological strategies against glucocorticoid-mediated brain damage during chronic disorders.
Martocchia A; Curto M; Toussan L; Stefanelli M; Falaschi P
Recent Pat CNS Drug Discov; 2011 Sep; 6(3):196-204. PubMed ID: 21834781
[TBL] [Abstract][Full Text] [Related]
8. Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children.
Edelmann MN; Sandman CA; Glynn LM; Wing DA; Davis EP
Psychoneuroendocrinology; 2016 Oct; 72():106-12. PubMed ID: 27393907
[TBL] [Abstract][Full Text] [Related]
9. Sleep and 24-h activity rhythms in relation to cortisol change after a very low-dose of dexamethasone.
Luik AI; Direk N; Zuurbier LA; Hofman A; Van Someren EJ; Tiemeier H
Psychoneuroendocrinology; 2015 Mar; 53():207-16. PubMed ID: 25635613
[TBL] [Abstract][Full Text] [Related]
10. Hypothalamic-pituitary-adrenal axis recovery following prolonged prednisolone therapy in infants.
Mendoza-Cruz AC; Wargon O; Adams S; Tran H; Verge CF
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1936-40. PubMed ID: 24081733
[TBL] [Abstract][Full Text] [Related]
11. The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal-pituitary (HPA) axis activity in healthy controls.
Buckley TM; Mullen BC; Schatzberg AF
Psychoneuroendocrinology; 2007; 32(8-10):859-64. PubMed ID: 17666187
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythms of glucocorticoid hormone actions in target tissues: potential clinical implications.
Kino T
Sci Signal; 2012 Oct; 5(244):pt4. PubMed ID: 23033538
[TBL] [Abstract][Full Text] [Related]
13. Evidence for ototopical glucocorticoid-induced decrease in hypothalamic-pituitary-adrenal axis response and liver function.
Abraham G; Gottschalk J; Ungemach FR
Endocrinology; 2005 Jul; 146(7):3163-71. PubMed ID: 15802495
[TBL] [Abstract][Full Text] [Related]
14. Role of glucocorticoid negative feedback in the regulation of HPA axis pulsatility.
Gjerstad JK; Lightman SL; Spiga F
Stress; 2018 Sep; 21(5):403-416. PubMed ID: 29764284
[TBL] [Abstract][Full Text] [Related]
15. Neonatal amygdala lesions lead to increased activity of brain CRF systems and hypothalamic-pituitary-adrenal axis of juvenile rhesus monkeys.
Raper J; Stephens SB; Henry A; Villarreal T; Bachevalier J; Wallen K; Sanchez MM
J Neurosci; 2014 Aug; 34(34):11452-60. PubMed ID: 25143624
[TBL] [Abstract][Full Text] [Related]
16. Role of the dorsomedial hypothalamus in glucocorticoid-mediated feedback inhibition of the hypothalamic-pituitary-adrenal axis.
Stamper CE; Hennessey PA; Hale MW; Lukkes JL; Donner NC; Lowe KR; Paul ED; Spencer RL; Renner KJ; Orchinik M; Lowry CA
Stress; 2015 Jan; 18(1):76-87. PubMed ID: 25556980
[TBL] [Abstract][Full Text] [Related]
17. Chronopharmacology of glucocorticoids.
Scherholz ML; Schlesinger N; Androulakis IP
Adv Drug Deliv Rev; 2019; 151-152():245-261. PubMed ID: 30797955
[TBL] [Abstract][Full Text] [Related]
18. Modeling the Influence of Seasonal Differences in the HPA Axis on Synchronization of the Circadian Clock and Cell Cycle.
Pierre K; Rao RT; Hartmanshenn C; Androulakis IP
Endocrinology; 2018 Apr; 159(4):1808-1826. PubMed ID: 29444258
[TBL] [Abstract][Full Text] [Related]
19. Circadian rhythms in rheumatology--a glucocorticoid perspective.
Spies CM; Straub RH; Cutolo M; Buttgereit F
Arthritis Res Ther; 2014 Nov; 16 Suppl 2(Suppl 2):S3. PubMed ID: 25608777
[TBL] [Abstract][Full Text] [Related]
20. Role of enhanced glucocorticoid receptor sensitivity in inflammation in PTSD: insights from computational model for circadian-neuroendocrine-immune interactions.
Somvanshi PR; Mellon SH; Yehuda R; Flory JD; Makotkine I; Bierer L; Marmar C; Jett M; Doyle FJ
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E48-E66. PubMed ID: 32315214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
